Testing in November 2026? You're studying the question patterns the current NCSBN test plan is built around.
All test banks

Most recent original material · Latest 2026 edition

Advance Pharm Study Guide

Explore Advance Pharm Study Guide, a completed original study PDF with its own purchase and secure delivery.

$19

Your PDF is ready. Continue to payment, then receive secure download access and delivery by email.

Write the exact name in full of the material you're looking for.

Free preview · Original latest version

Sample questions from Advance Pharm Study Guide

This material has 24 questions with answers and rationales. Here are the first 5.

  1. 1.An older adult receiving intravenous vancomycin for a serious MRSA infection develops acute kidney injury. The estimated vancomycin clearance falls by approximately 50%, while the volume of distribution remains unchanged. Which pharmacokinetic interpretation and management approach is most appropriate?

    • A.The elimination half-life will decrease; shorten the dosing interval to maintain exposure.
    • B.The elimination half-life will approximately double; reassess maintenance dosing using kidney function and AUC-guided monitoring.
    • C.The loading dose must double because reduced clearance decreases the initial drug concentration.
    • D.The maintenance regimen should remain unchanged because intravenous administration bypasses renal elimination.

    Rationale: Half-life equals approximately 0.693 times volume of distribution divided by clearance, so halving clearance approximately doubles half-life. Maintenance dosing should be reassessed to prevent accumulation, using kidney function and AUC-guided monitoring. Shortening the interval would increase accumulation. Loading doses primarily depend on volume of distribution and target concentration, not clearance. Intravenous administration bypasses absorption, not elimination.

  2. 2.A patient with heart failure with reduced ejection fraction takes sacubitril/valsartan, carvedilol, spironolactone, and furosemide. During medication reconciliation, the nurse learns that the patient recently started taking potassium chloride left over from an earlier prescription. The patient reports weakness, and laboratory testing shows potassium 6.2 mEq/L. Which action is the priority?

    • A.Continue the regimen because furosemide prevents clinically important hyperkalemia.
    • B.Recommend a potassium-containing salt substitute and repeat laboratory testing in one week.
    • C.Arrange immediate monitored evaluation, withhold potassium supplementation, and urgently review medications that increase potassium.
    • D.Discontinue carvedilol permanently because beta blockers are contraindicated in chronic systolic heart failure.

    Rationale: Potassium of 6.2 mEq/L with weakness requires urgent evaluation and cardiac monitoring because potentially fatal dysrhythmias can occur. Potassium supplementation, spironolactone, and valsartan can contribute. Furosemide does not reliably prevent hyperkalemia. Potassium-containing salt substitutes would worsen the problem, and delayed reassessment is unsafe. Carvedilol is an evidence-based treatment for stable systolic heart failure and should not be permanently discontinued on this rationale.

  3. 3.A patient with type 2 diabetes takes empagliflozin and basal insulin. After two days of vomiting and minimal food intake, the patient develops abdominal pain and rapid breathing. Glucose is 186 mg/dL, bicarbonate is 12 mEq/L, the anion gap is elevated, and serum beta-hydroxybutyrate is markedly elevated. Which management plan is most appropriate?

    • A.Continue empagliflozin and use oral fluids because glucose below 250 mg/dL excludes diabetic ketoacidosis.
    • B.Hold basal insulin and give a sulfonylurea to reduce glucose without worsening dehydration.
    • C.Treat with sodium bicarbonate alone until the bicarbonate concentration normalizes.
    • D.Stop empagliflozin and initiate urgent ketoacidosis treatment with fluids, insulin, electrolyte monitoring, and dextrose as needed.

    Rationale: SGLT2 inhibitors can cause ketoacidosis with only modest glucose elevation, especially during fasting or acute illness. Treatment requires stopping the drug and providing fluids, insulin, potassium-guided electrolyte management, and dextrose to permit continued insulin while clearing ketones. Glucose below 250 mg/dL does not exclude ketoacidosis. Withholding insulin can worsen ketogenesis, and sulfonylureas do not treat it. Bicarbonate alone does not correct the underlying process and is not routinely indicated.

  4. 4.A patient taking clozapine for treatment-resistant schizophrenia smokes one pack of cigarettes daily. On admission to a smoke-free hospital, the patient stops smoking and begins a nicotine patch. Five days later, marked sedation and orthostatic hypotension develop. Which explanation and response are most appropriate?

    • A.Stopping tobacco smoke exposure reduces CYP1A2 induction; assess clozapine toxicity, obtain a level when appropriate, and collaborate on dose adjustment.
    • B.Nicotine replacement strongly induces CYP1A2; increase clozapine to compensate for accelerated metabolism.
    • C.Smoking cessation increases clozapine renal clearance; administer an additional dose to prevent relapse.
    • D.The symptoms establish nicotine withdrawal; continue clozapine unchanged without further assessment.

    Answer and rationale are in the full material.

  5. 5.Immediately after receiving an intravenous antibiotic, a patient develops generalized urticaria, wheezing, throat tightness, and blood pressure of 78/44 mm Hg. The antibiotic infusion is stopped and emergency assistance is activated. An order specifies epinephrine 0.5 mg intramuscularly using a 1 mg/mL solution. Which action correctly implements the priority medication treatment?

    • A.Administer 5 mL of the solution intramuscularly into the deltoid.
    • B.Administer 0.5 mL of the solution intramuscularly into the mid-anterolateral thigh.
    • C.Administer intravenous diphenhydramine first and defer epinephrine until the rash resolves.
    • D.Administer inhaled albuterol alone because wheezing identifies isolated bronchospasm.

    Answer and rationale are in the full material.

+19 more questions with answers and rationales

Create a free account to save this material and start studying. Pro members get full access to every test bank.

Sign up free

Look inside

Free · 60 seconds

Create a free account

Save this guide, track progress and find your purchases in your dashboard.

or email

Already have an account? Sign in

Released November 20, 2026 · Independent original practice and study material.